Smart Inhalers Market is estimated to expand at a CAGR of 10.2% to reach US$ 235.7 Mn by the end of 2033

A smart inhaler is a medical device that tracks and records the usage of the inhaler and wirelessly transmits the data to a mobile application or web-based platform. This allows patients to monitor their medication usage and adherence, and also provides physicians with valuable information to optimize treatment plans. Smart inhalers can also include features such as dose counters, reminders, and sensor-based monitoring systems.

Worldwide revenue from the smart inhalers market stands at US$ 80.5 Mn in 2022, with the global market estimated to expand at a CAGR of 10.2% to reach US$ 235.7 Mn by the end of 2033.

Request For Free Sample Report of "Smart Inhalers Market"@ https://www.persistencemarketresearch.com/samples/26881

The global smart inhalers market is expected to grow at a significant rate during the forecast period, driven by factors such as increasing prevalence of respiratory diseases, growing adoption of digital health solutions, and rising awareness about the benefits of smart inhalers.

The market is segmented based on product, application, and end-user. On the basis of product, the market is segmented into dry powder inhalers (DPI) and metered dose inhalers (MDI). On the basis of application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. On the basis of end-user, the market is segmented into hospitals, clinics, and home care settings.

Companies

OPKO Health, Inc
AstraZeneca plc
GlaxoSmithKline Plc.
Propeller Health
Aptar Pharma
Adherium Limited
Novartis AG
Boehringer Ingelheim
Teva Pharmaceutical Industries Ltd
H&T Presspart Manufacturing Ltd.
Sensirion AG
Cohero Health, Inc.
RYAH Medtech Inc.

 Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/26881

The major players operating in the smart inhalers market include GlaxoSmithKline plc, AstraZeneca, Novartis AG, Boehringer Ingelheim GmbH, Propeller Health, and others. These players have adopted various strategies, such as partnerships, collaborations, and new product launches, to increase their share in the market.

In conclusion, the global smart inhalers market is expected to grow at a significant rate during the forecast period, driven by factors such as increasing prevalence of respiratory diseases, growing adoption of digital health solutions, and rising awareness about the benefits of smart inhalers. The major players operating in the market are focusing on strategies such as partnerships, collaborations, and new product launches to increase their share in the market.

Competitive Landscape

To enhance their market position, players in the market are putting more and more emphasis on partnerships, acquisitions, mergers, and expansion.

For instance,

Adherium Limited formed a partnership with Trudell Medical Limited in August 2022 to provide remote monitoring and respiratory eHealth solutions to patients in the United States. With the aim of lowering readmissions and improving patient outcomes, both businesses will examine COPD patients after they leave the hospital utilising the Trudell U.S. unit Monaghan Health center and its subsidiary Aetonix's TouchAway platform in conjunction with Adherium's Hailie sensors.
The U.S. FDA 510(k) approved the Hailie Sensor, which contains physiological parameters for monitoring the use of asthma and COPD medicines for sale in the U.S. region, in September 2021, according to an announcement made by Adherium Limited, a major player in the respiratory eHealth remote monitoring market.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/26881

Key Segments of the Smart Inhalers Industry Research

By Product:

Dry Powder Inhaler (DPI)- based Smart Inhalers
Metered Dose Inhaler (MDI)- based Smart Inhalers

By Disease Indication:

Asthma
COPD

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

 For More Premium Insights, Check out the Link:

Bioinks market - https://www.globenewswire.com/en/news-release/2022/09/12/2514213/0/en/Bioinks-Market-Size-to-climb-of-US-738-2-Mn-by-the-end-of-2032-Persistence-Market-Research.html

Tumour-Induced Osteomalacia market - https://www.globenewswire.com/en/news-release/2022/09/08/2512703/0/en/Tumour-Induced-Osteomalacia-Market-estimated-to-move-ahead-at-a-value-CAGR-of-2-8-by-the-end-of-2032-Persistence-Market-Research.html

Skin Imaging Systems market - https://www.globenewswire.com/en/news-release/2022/08/22/2502306/0/en/Skin-Imaging-Systems-Market-predicted-to-expand-at-a-high-CAGR-of-7-by-the-end-of-2032-Persistence-Market-Research.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.